BIO-GATE AGBIO-GATE AGBIO-GATE AG

BIO-GATE AG

No trades
Buy BIG1

BIG1 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Bio-Gate AG engages in the development and production of technologies and solutions for health and hygiene, primarily used in orthopedics, traumatology, and vascular surgery. The firm offers MicroSilver BG, which is pure elemental microporous silver additive with antimicrobial properties, as well as HyProtect, which is an ultrathin plasma coating that protects surfaces of medical implants against bacteria. Its technologies are also used to incorporate antimicrobial properties into cosmetics including industrial and consumer products. The company was founded on December 2, 2005 and is headquartered in Nuremberg, Germany.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

BIG1 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company